A clinical study of serum phosphate and magnesium in type II diabetes mellitus

Authors

  • B. Srinivasa Rao Department of General Medicine, GEMS Hospital, Ragolu, Srikakulam, AP, India.
  • M. Malleswara Rao Department of General Medicine, GEMS Hospital, Ragolu, Srikakulam, AP, India.
  • C H Ratnakumar Professor and Head, Department of Biochemistry, Hospital, Ragolu, Srikakulam, AP, India

Keywords:

Magnesium, phosphate, type 2 diabetes mellitus

Abstract

Objective: To assess serum phosphate and magnesium level in type-2 diabetic patients in comparison with those of control subjects. Methodology: There were 100 diabetic patients and 100 age matched non-diabetic (control) subjects included in this study. Serum phosphate, serum magnesium and fasting and postprandial blood sugar measured among the diabetic and control groups using SPSS version 16.0 for analysis. Results: Serum phosphate level was significantly lower in diabetic patients (2.92 ± 0.75) as compared to control subjects (3.38 ± 0.49). Serum magnesium levels were significantly lower in diabetic patients (0.9 ± 0.15) compared to controls (2.75 ± 0.46) Conclusion: The study reveals that hyperglycemia may reduce serum levels of magnesium and phosphorus.

Downloads

Published

2015-12-16

How to Cite

B. Srinivasa Rao, M. Malleswara Rao, & C H Ratnakumar. (2015). A clinical study of serum phosphate and magnesium in type II diabetes mellitus. World Journal of Pharmaceutical Sciences, 3(12), 2486–2489. Retrieved from https://wjpsonline.com/index.php/wjps/article/view/clinical-study-serum-phosphate-magnesium-diabetes-mellitus

Issue

Section

Research Article